NXL Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03
Price $5.73
Market Cap (MRQ) $126M
P/E (TTM) -12.2
EPS (TTM) $-0.47
Revenue (TTM) $217.2K
ROE (TTM) -240.3%
52W Range $4–$60

NXL Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04
range
bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

Stock splits 1
Ex-date Split Type
Aug. 31, 2026 1-for-30 Reverse

10-Year Performance Revenue, net income, margins and EPS trends

06
Revenue$301.6K
2021-12-31 → 2025-12-31
EPS$-0.50
2022-12-31 → 2025-12-31
Net margin-4139.4%
2022-12-31 → 2025-12-31
Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric 5Y trend NXL 5Y avg Peer Median Verdict
P/E (TTM) -12.25Y avg ≈-1.9 ≈-1.9 · ·
P/S (TTM) 580.65Y avg ≈71.1 ≈71.1 2.8 Overvalued
P/B (MRQ) 83.05Y avg ≈3.7 ≈3.7 1.2 Overvalued
Price / Cash Flow -22.25Y avg ≈-3.7 ≈-3.7 · ·
Price / Tangible Book (MRQ) 112.65Y avg ≈4.0 ≈4.0 · ·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14
Avg Surprise -25.7%
Next Report Nov 12, 2026
PeriodReportEPS ActualEPS EstSurprise
June 30, 2026 Aug 4, 2026 $-3.30 $-3.03 -8.9%
March 31, 2026 May 11, 2026 $-3.30 $-3.03 -8.9%
Dec. 31, 2025 $-3.81 $-3.64 -4.8%
Sept. 30, 2025 $-3.90 $-3.64 -7.3%
June 30, 2025 $-0.10 $-0.14 29.3%
March 31, 2025 $-0.15 $-0.10 -48.5%
Dec. 31, 2024 $-0.28 $-0.12 -131.0%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15
Income Statement 16
Metric Trend 20252024202320222021
Revenue $301.6K$168.7K$110.7K$1M$144.1K
Cost of Revenue $61.4K$36.6K$25.7K$363.2K$21.4K
Gross Profit $240.3K$132.1K$85.1K$958.1K$122.6K
R&D Expense $1M$1M$2M$511.0K$139.0K
SG&A Expense $4M$4M$2M$1M$5M
Operating Expenses $9M$8M$6M$3M$6M
Operating Income $-8M$-8M$-6M$-2M$-6M
Interest Expense $-8.2K$-3.2K$38.8K$59.4K$82.3K
Other Non-op $169.7K$142.6K$1M$135.2K$-59.4K
Pretax Income $-8M$-8M$-5M··
Net Income $-8M$-8M$-5M$-2M$-6M
EPS (Basic) $-0.50$-0.83$-0.63$-0.30·
EPS (Diluted) $-0.50$-0.83$-0.63$-0.30·
Shares (Basic) 16,392,4659,215,7727,357,0295,572,402·
Shares (Diluted) 16,392,4659,215,7727,357,0295,572,402·
EBITDA $-8M$-8M$-6M$-2M·
Balance Sheet 24
Metric Trend 20252024202320222021
Cash & Equivalents $654.8K$574.5K$580.2K$162.7K$661.8K
Short-term Investments $3M$3M$2M$7M·
Receivables $81.6K$13.0K$9.4K$4.9K$16.3K
Inventory $131.5K$174.6K$156.4K$154.4K$31.4K
Prepaid Expense $363.0K$293.6K$315.7K$272.3K$43.2K
Current Assets $4M$4M$3M$7M$752.7K
PP&E (Net) ···$503$1.0K
Accum. Depreciation $2.7K·$2.7K$2.2K$29.9K
Intangibles $336.0K$260.7K$105.5K··
Total Assets $5M$4M$4M$7M$753.7K
Accounts Payable $244.6K$155.9K$159.5K$658.4K$843.8K
Accrued Liabilities $642.8K$390.7K$261.3K$539.8K$611.8K
Short-term Debt ···$500.0K$500.0K
Current Liabilities $887.3K$546.7K$425.3K$2M$2M
Capital Leases ···$4.5K$49.1K
Total Liabilities $887.3K$546.7K$425.3K$2M$2M
Total Debt ···$500.0K·
Common Stock $19.2K$13.3K$7.4K$7.3K$4.9K
Paid-in Capital $97M$88M$80M$78M$69M
Retained Earnings $-93M$-85M$-77M$-72M$-71M
AOCI $406$-513$-405$36.3K·
Stockholders' Equity $4M$4M$3M$5M$-2M
Liabilities + Equity $5M$4M$4M$7M$753.7K
Shares Outstanding 19,186,34613,303,5237,436,5627,286,5624,879,923
Cash Flow 8
Metric Trend 20252024202320222021
Stock-based Comp $3M$4M$2M$270.7K$4M
Amort. of Intangibles $21.5K$15.1K···
Operating Cash Flow $-5M$-4M$-4M$-2M$-1M
Investing Cash Flow $-132.0K$-577.5K$4M$-7M·
Stock Issued $5M$5M·$9M$1M
Net Stock Activity $5M$5M·$9M·
Financing Cash Flow $5M$5M$-200.0K$9M$2M
Taxes Paid $0$0···
Profitability 7
Metric Trend 20252024202320222021
Gross Margin 79.7%78.3%76.8%72.5%·
Operating Margin -2781.7%-4596.1%-5143.5%-138.7%·
Net Margin -2725.8%-4508.7%-4197.6%-128.5%·
Pretax Margin -2725.4%-4511.6%···
EBITDA Margin -2781.7%-4596.1%-5143.5%-138.7%·
ROA -185.6%-193.7%-84.0%-41.5%·
ROE -169.3%-176.2%-144.3%-28.7%·
Liquidity & Solvency 4
Metric Trend 20252024202320222021
Current Ratio 4.87.28.13.8·
Quick Ratio 4.36.47.03.6·
Debt / Equity ···0.1·
Interest Coverage 1018.32428.6-146.7-30.9·
Efficiency 3
Metric Trend 20252024202320222021
Asset Turnover 0.10.00.00.3·
Inventory Turnover 0.40.20.23.9·
Receivables Turnover 6.415.115.6124.8·
Per Share 5
Metric Trend 20252024202320222021
Book Value / Share $0.20$0.28$0.43$0.75·
Revenue / Share $0.02$0.02$0.02··
Cash Flow / Share $-0.30$-0.43$-0.52··
Cash / Share $0.03$0.04$0.08$0.02·
EPS (TTM) $-0.50$-0.83$-0.63$-0.30·
Growth Rates 2
Metric Trend 20252024202320222021
Revenue YoY 78.8%52.3%-91.6%817.2%·
Revenue CAGR 3Y -38.9%5.4%···
Valuation (TTM) 12
Metric Trend 20252024202320222021
Revenue TTM $301.6K$168.7K$110.7K$1M·
Net Income TTM $-8M$-8M$-5M$-2M·
Market Cap $11M$37M$3M$5M·
Enterprise Value ···$-1M·
P/E -1.1-3.3-0.6-2.5·
P/S 35.5217.627.24.1·
P/B 2.910.00.91.0·
P / Tangible Book 3.110.81.01.0·
P / Cash Flow -2.2-9.3-0.8-2.5·
EV / EBITDA ···0.6·
EV / Revenue ···-0.8·
Earnings Yield -89.6%-30.1%-155.6%-40.1%·

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16
Metric 2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue $301.6K $168.7K $110.7K $1M $144.1K
Gross Margin % 79.7% 78.3% 76.8% 72.5% ·
Operating Margin % -2781.7% -4596.1% -5143.5% -138.7% ·
Net Income $-8M $-8M $-5M $-2M $-6M
Diluted EPS $-0.50 $-0.83 $-0.63 $-0.30 ·

Institutional owners (13F) 22 filers · $391K total · As of June 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 22
Value held $391K
New positions 4
Exited positions 7
Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
4 (-5 vs prior Q) 7 (+3 vs prior Q) 2 (-1 vs prior Q) 5 (-2 vs prior Q) -217K

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
VANGUARD GROUP INC $99,280 177,922 25.38% Shares
PEAK6 LLC $79,269 240,210 20.27% Shares
GEODE CAPITAL MANAGEMENT, LLC $46,062 139,583 11.78% Shares
VANGUARD CAPITAL MANAGEMENT LLC $41,757 126,536 10.68% Shares
CITADEL ADVISORS LLC $24,881 75,398 6.36% Shares
JANE STREET GROUP, LLC $21,614 65,497 5.53% Shares
VANGUARD FIDUCIARY TRUST CO $16,957 51,386 4.34% Shares
STATE STREET CORP $10,659 32,300 2.73% Shares
Atria Wealth Solutions, Inc. $10,221 10,347 2.61% Shares
UBS Group AG $8,852 26,825 2.26% Shares
Kovack Advisors, Inc. $8,039 22,325 2.06% Shares
NORTHERN TRUST CORP $7,953 24,100 2.03% Shares
StoneX Group Inc. $5,405 13,497 1.38% Shares
RAYMOND JAMES FINANCIAL INC $3,993 12,100 1.02% Shares
Integrated Investment Consultants, LLC $3,300 10,000 0.84% Shares
Tower Research Capital LLC (TRC) $697 2,111 0.18% Shares
OSAIC HOLDINGS, INC. $693 2,100 0.18% Shares
CITIGROUP INC $481 1,459 0.12% Shares
WELLS FARGO & COMPANY/MN $330 1,000 0.08% Shares
Farther Finance Advisors, LLC $330 1,000 0.08% Shares
Federation des caisses Desjardins du Quebec $288 873 0.07% Shares
BARCLAYS PLC $80 241 0.02% Shares

Activists & 5%+ owners 1 position

18

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
Greenlight Ventures, LLC Sept. 3, 2026 5.60% Initial filing Board campaign SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Company insiders 8 insiders · 4 officers · 6 directors

19
Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Mark White CEO Dec. 19, 2025 A 309,127 0 0 $0
Justin Van Fleet CFO Dec. 19, 2025 A · 0 0 $0
Carolyn Hamby Shelton Sr. VP - Quality - Regulatory Dec. 19, 2025 A 30,000 0 0 $0
David Owens Chief Medical Officer Dec. 19, 2025 A 191,252 0 0 $0
Alan Kazden Director Dec. 19, 2025 A 119,590 0 0 $0
Ben Hu Director Dec. 19, 2025 A 377,095 0 0 $0
Leslie Bernhard Director Sept. 30, 2024 A 49,838 0 0 $0
Rick Morad Director Sept. 16, 2022 P 108,341 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 8 ETFs

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
ISCF · iShares Trust 0.01% 55,146 SH Sept. 10, 2026 Daily
VXF · VANGUARD INDEX FUNDS 0.00% 126,536 SH Aug. 19, 2026 Daily
VXUS · VANGUARD STAR FUNDS 0.00% 3,029,583 SH Aug. 19, 2026 Daily
VPL · VANGUARD INTERNATIONAL EQUITY INDEX… 0.00% 272,036 SH Aug. 19, 2026 Daily
VT · VANGUARD INTERNATIONAL EQUITY INDEX… 0.00% 133,663 SH Aug. 19, 2026 Daily
VSS · VANGUARD INTERNATIONAL EQUITY INDEX… 0.00% 761,578 SH Aug. 19, 2026 Daily
VEA · VANGUARD TAX-MANAGED FUNDS 0.00% 1,977,277 SH Aug. 19, 2026 Daily
VSGX · VANGUARD WORLD FUND 0.00% 38,378 SH Aug. 19, 2026 Daily

NXL Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21
rating · 5 analysts BUY
Median target $60.00 +947.1%
1 20.0% Strong Buy
3 60.0% Buy
1 20.0% Hold
0 0.0% Sell
0 0.0% Strong Sell

12-Month Price Target

1 analysts · 2026-10-02

Mean target $60.00 +947.1%

Low$60.00 Mean$60.00 High$60.00

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
NXL $11M -1.1 78.8% -2725.8% -169.3% 79.7%
AMIX · · · · · ·
INBS $7M -0.3 38.1% -294.9% -292.2% 48.6%
NVNO $210.6K -0.0 · · -64.7% ·
IVF · -0.0 4.7% · · ·
XAIR $8M -0.2 107.3% -433.0% -337.4% 3.3%
TNON · · · · · ·
BJDX $403.2K -0.0 · · -121.6% ·
ADGM · -0.7 · · · ·
ABT $250.18B 33.7 5.7% 14.7% 13.1% ·

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Source: SEC 10-Q filed Aug 12, 2026